Venrock public
[search 0]
Download the App!
show episodes
 
Artwork

1
Running Through Walls

Venrock, a venture capital firm

Unsubscribe
Unsubscribe
Monthly
 
Running Through Walls is a Venrock podcast featuring candid conversations between investors and entrepreneurs. Each episode, we offer a behind-the-scenes look at the breakthroughs, challenges and nuttiness associated with building and growing companies. Venture capital firm Venrock has been investing in entrepreneurs across technology and healthcare since 1969.
  continue reading
 
Welcome to Jeremy takes on HIT, Healthcare Information Tech. Hear about the week's biggest stories from just the fax, to why you should care, to Jeremy's take. Support this podcast: https://podcasters.spotify.com/pod/show/jeremytakesonhit/support
  continue reading
 
Loading …
show series
 
Sami Inkinen, founder and CEO of Virta Health, speaks with Venrock partner Bob Kocher to discuss how Virta has evolved since he was on the podcast seven years ago. Inkinen shares how he views the GLP-1 craze, insights on his go-to-market strategy, advice for founders entering the healthcare market, and how Virta uses AI and technology.…
  continue reading
 
Latané Conant, Chief Revenue Officer at 6sense, speaks with Venrock partner Brian Ascher to discuss how her previous marketing role prepared her for her promotion to Chief Revenue Officer. Conant shares her approach to keeping product market fit, her opinion on Marketing Qualified Leads (MQLs), how AI could impact sales and marketing and more.…
  continue reading
 
Isan Chen, CEO of MBrace Therapeutics, speaks with Venrock partner Racquel Bracken to discuss his career trajectory leading up to his founding of MBrace. Chen shares the impetus behind his decision to become an oncologist, why he switched from academic medicine to the industry side, lessons learned from years in drug development and more.…
  continue reading
 
Ed Park, co-founder and CEO of Devoted Health, sits down with Venrock partners Bryan Roberts and Bob Kocher to discuss the founding of Devoted. Park talks about his priorities for the next five years, the value he sees in AI and LLMs, Medicare Advantage industry changes, his favorite interview question for job candidates and more.…
  continue reading
 
Ying Huang, CEO of Legend Biotech, speaks with Venrock partner Nimish Shah about his career path to Legend Biotech and the lessons he learned from transitioning from Wall Street to an operating role. Huang also discusses what he prioritized when he first started the role, the most rewarding parts of his job and what characteristics he looks for whe…
  continue reading
 
Brad Stulberg, best-selling author of The Practice of Groundedness and co-author of Peak Performance, speaks with Venrock partner Bob Kocher about Stulberg’s new book, Master of Change: How to Excel When Everything is Changing—Including You. Stulberg and Kocher discuss ways to rethink change, the concept of rugged flexibility and paths for embracin…
  continue reading
 
Senthil Sundaram, CEO of Terns Pharmaceuticals, speaks with Venrock’s Nimish Shah about the lessons learned balancing personal health events while being CEO of a young company. Sundaram also discusses the "Working Genius" model, an approach focused on leveraging the types of work that bring an employee energy, and his attitude towards team-based le…
  continue reading
 
Dr. Sheila Gujrathi, a biotech industry veteran with a strong track record as an entrepreneur, physician executive, translational scientist, board member, and drug developer, speaks with Venrock’s Nimish Shah about the lessons learned in her career at biotech companies both big (Genentech) and small (Gossamer Bio, Receptos, Inc.). Dr. Gujrathi also…
  continue reading
 
Sam Kintz, co-founder, and CEO of Enliven Therapeutics, speaks with Venrock partner Nimish Shah about the journey that led him to found Enliven. Kintz delves into lessons learned during his time at Roche Venture Fund, and how his time at Stemcentrx and Abbvie revealed what truly matters most to him – being a part of an entire drug development story…
  continue reading
 
Venrock partners Andrew Gottesdiener and Nimish Shah speak with Michael Henderson, CEO of Apogee Therapeutics, about his role’s unique challenges and opportunities. Henderson discusses his accelerated career trajectory, valuable lessons that have helped shape his success, and Apogee’s recent Series B financing round. Henderson delves into the impor…
  continue reading
 
Venrock’s Nick Beim speaks with Steve Lockshin, founder of Vanilla, about lessons learned as a serial entrepreneur in wealth management services. Lockshin shares what drives him as an entrepreneur, the need for more digestible information in estate planning, and his most valuable lessons learned on the path to building Vanilla. Lockshin also discus…
  continue reading
 
Venrock partner Nick Beim speaks with Bill McNabb, former chairman and CEO of Vanguard, an asset management company that pioneered low-cost investing for the consumer. McNabb shares important leadership lessons including the importance of being humble, having a clear definition of success, and knowing what makes a high-performing team. McNabb revea…
  continue reading
 
Farzad Mostashari, founder and CEO of Aledade, speaks with Venrock’s Bryan Roberts and Bob Kocher about improving the quality and efficiency of patient care with a focus on preventative care. With the recent launch of Aledade Care Solutions and new focus on Medicare Advantage, Mostashari delves into Aledade’s efforts to scale and deliver where aver…
  continue reading
 
Venrock partners Bryan Roberts and Bob Kocher, speak with Heather Fernandez, co-founder and CEO of Solv, about Solv’s mission, building more cap table diversity in tech, and the healthcare field today. Fernandez delves into Solv’s Series C funding round where she created a special purpose vehicle (SPV) focused on women of color, bringing in first-t…
  continue reading
 
Larry Hamann, co-founder, president, and CEO of Interdict Bio, speaks with Venrock Vice President Mariana Mihalusova about lessons learned from his career in drug discovery. Hamann delves into where his love for organic chemistry stems from and why inclusive environments are essential to building successful teams. He also speaks about the do’s and …
  continue reading
 
Venrock partner Bob Kocher speaks with Dr. Drew Altman, CEO of the Henry J. Kaiser Family Foundation (KFF) and founding publisher of Kaiser Health News (KNH), about dealing with misinformation and skepticism with expertise and facts. Altman reveals how misinformation, fragmented media, and a broken political system exacerbate the public’s low trust…
  continue reading
 
Jim Del Favero, Head of Product at Figure, a fintech company using blockchain to help homeowners better tap their home equity, joins Venrock partner Brian Ascher to discuss what makes a great product manager. Del Favero reveals why great PMs focus on outcomes, not outputs, and critically think about the problem that needs to be solved. Del Favero a…
  continue reading
 
Venrock partner Brian Ascher speaks with Nicole Alvino, co-founder and CEO of Firstup, about effective workforce communication both digitally and in person. Alvino highlights fostering employee connection through authentic and transparent communication, using the power of video to drive engagement, and discusses expectations for corporate social re…
  continue reading
 
Company success is predicated on the people, according to Daversa Partners founder and CEO, Paul Daversa. Venrock partner Bryan Roberts chats with Daversa about the nuances of recruiting impactful senior-level leadership candidates who are a fit for the needs of the company. They cover hiring high will over high skill, understanding that candidates…
  continue reading
 
Venrock partner Andrew Gottesdiener speaks with Jigar Raythatha, former CEO of Constellation Pharmaceuticals, about lessons learned from his time at Constellation. As Constellation has evolved from an early-stage company to being acquired by MorphoSys, Raythatha dives into its many life-cycles, his heavy involvement in the recruitment process, and …
  continue reading
 
Venrock partner Racquel Bracken speaks with Markus Renschler, President and CEO of Cyteir Therapeutics, to discuss the journey that led him to Cyteir, and the company’s path to going public. Renschler dives into an important lesson his parents instilled in him from a young age, “be comfortable with being uncomfortable,” and explains how this lesson…
  continue reading
 
With rising reports of Omicron in the United States, Venrock partner Bryan Roberts speaks with Dr. Charity Dean, CEO and co-founder of Public Health Company (PHC), to discuss her predictions and concerns for the latest Covid-19 variant. Dean and Roberts also talk about the long-term societal impacts of Covid, the severity of disease, and which grou…
  continue reading
 
Brad Stulberg, bestselling author of the books ‘The Passion Paradox’ and ‘Peak Performance,’ joins Venrock partner Bob Kocher to discuss his newest book, ‘The Practice of Groundedness.’ Stulberg offers a healthier, more sustainable model for success and dives into what groundedness means to him – a sense of feeling solid, stable, and whole; in a wa…
  continue reading
 
Venrock partner Bob Kocher speaks with Ashish Jha, MD, MPH, Professor and Dean at Brown University School of Public Health, about the importance of interdisciplinary approaches and knowledge translation in tackling big public health problems. Dr. Jha delves into the journey that led him to become Dean at Brown University and his thoughts on academi…
  continue reading
 
Not knowing where items are located, what’s in stock, or if they are properly priced cost the global retail industry more than a trillion dollars. Venrock partner David Pakman speaks with Brad Bogolea, co-founder and CEO of Simbe Robotics, about how Simbe’s robot Tally is solving these major blind spots. Bogolea delves into how robotic solutions ca…
  continue reading
 
Vlad Coric, M.D., CEO of Biohaven Pharmaceuticals, joins Venrock partner Nimish Shah to speak about the significance of innovation and creativity across all aspects of a business. Coric dives into the challenges of launching Biohaven’s drug, Nurtec ODT, during the pandemic and why he believed it was their moral duty to continue the drug supply chai…
  continue reading
 
Venrock partner Nick Beim speaks with Jason Wenk, founder and CEO of Altruist, about his mission to increase the accessibility of great financial advice. Wenk walks through his early entrepreneurial endeavors and explains how they’ve contributed to the creation of Altruist. As his leadership style has evolved over the years, Wenk shares the biggest…
  continue reading
 
Cyrus Harmon, co-founder and CTO of Olema Oncology, joins Venrock partner Alex Rosen to discuss the history of Olema. Olema had a successful IPO last year and Harmon sheds light on what biotech companies should look for when selecting banks for an IPO and how to build momentum for financing rounds. He also dives into the factors that led to the fou…
  continue reading
 
Venrock partner Camille Samuels speaks with Angie You, CEO of Amunix, and Rich Heyman, Chairman of the Board, about the dynamics between a CEO and a Chairperson that foster a successful company. You and Heyman dive into the importance of mutual trust and respect between a CEO and the Board, and You shares her passion for people that makes her such …
  continue reading
 
Eric Brown, CEO of Dynamic Signal, joins Venrock partner Brian Ascher to speak about diversity, equity, and inclusion. Brown believes you can’t have great culture without putting inclusion first, which is why it was the first thing on his agenda as he stepped into his role as CEO of Dynamic Signal last year. Brown discusses some of the company’s in…
  continue reading
 
Venrock Partner Mike Tyrrell speaks with Jason Purcell, co-founder and CEO of Salsify to discuss his career and how Endeca’s $1B exit lead to the creation of Salsify. Purcell explains how we are in the midst of a “masses of markets” world, and delves into how commerce experience management platforms like Salsify are helping brands navigate a space …
  continue reading
 
Dataminr uses AI to detect when major events are happening, long before the first news reports emerge. How is this possible? Venrock’s Nick Beim chats with Dataminr’s co-founder and CEO Ted Bailey to discuss how the rise of real-time data platforms and misinformation around the 9/11 attacks helped spark the idea for the company. He shares how Datam…
  continue reading
 
Emily Drabant Conley, CEO of Federation Bio, joins Venrock partner Racquel Bracken to chat about lessons learned from her time at 23andMe and how Federation Bio is disrupting the microbiome space. Conley discusses key takeaways from her experience in handling moments of crisis, including the importance of transparency and staying consistent with yo…
  continue reading
 
Venrock partner Nimish Shah speaks with Jason Fenton, managing director and head of healthcare capital markets at Cowen, to discuss the explosion of activity in the biotech IPO market this year. Fenton dives into the pros and cons of a virtual IPO process and shares best practices for companies looking to go public. Shah and Fenton outline some of …
  continue reading
 
Ryan Nece is a former NFL player, Super Bowl winner, and now a venture capitalist at Next Play Capital. He joins Venrock partner Brian Ascher to chat about the transition from the field to the boardroom, including why so many professional athletes take an interest in venture capital and what elite athletes and successful entrepreneurs have in commo…
  continue reading
 
Venrock partner Bob Kocher speaks with Hill Ferguson, CEO of Doctor On Demand, about how the company managed a huge spike in demand for virtual care as COVID-19 spread throughout the country beginning in March 2020. He shares how Doctor On Demand implemented a real-time assessment for higher-risk patients to handle growing wait times, and how they …
  continue reading
 
Jennifer Bisceglie, CEO and founder of Interos, joins Venrock partner Nick Beim to discuss how Interos mitigates the challenges of third party risk management, particularly during the pandemic, by providing customers full visibility of their extended supply chain. Bisceglie describes how Interos continuously builds “family trees” of companies and s…
  continue reading
 
Venrock partner Camille Samuels speaks with Corvidia co-founders Ram Aiyar and Michael Davidson about Corvidia’s recent acquisition by Novo Nordisk, just four years after its founding. They discuss how inflammation contributes to cardiovascular disease – the number one killer in the United States – and how their drug Ziltivekimab “Zilti” is proving…
  continue reading
 
Latane Conant, CMO of 6sense, joins Venrock partner Brian Ascher to chat about marketing strategy for B2B companies and the role of marketing in corporate culture. They discuss the “First Sip Club” which Conant started during the pandemic to stay connected to fellow SaaS marketers, and she shares how it has evolved to stay relevant in a rapidly cha…
  continue reading
 
Healthcare industry veteran George Barrett joins Venrock partner Bob Kocher to discuss how the U.S. handled the unprecedented demand for PPE (personal protective equipment) for healthcare providers during the COVID-19 pandemic. Barrett explains the significance of examining all components at the supply chain level to create a system that is more fl…
  continue reading
 
Venrock partner David Pakman speaks with Roham Gharegozlou, CEO and founder of Dapper Labs about launching CryptoKitties, one of the world's first and most successful blockchain games, and shares his predictions for how crypto gaming will evolve in the next decade. They also discuss the launch of NBA Top Shot, a new kind of digital collectible that…
  continue reading
 
Following up on their discussion of COVID-19 vaccines and therapeutics, Venrock partner Bryan Roberts speaks with Mathai Mammen, Global Head of R&D at the Janssen Pharmaceutical Companies of Johnson & Johnson, about Mammen’s career path and what differences he’s found working on drug development in both small companies and large companies. Managing…
  continue reading
 
Venrock partner Bryan Roberts chats with Mathai Mammen about COVID-19 vaccine development and therapeutics in this special episode of Running Through Walls. Mammen serves as the Global Head of R&D at the Janssen Pharmaceutical Companies of Johnson & Johnson, where he is heading up the firm’s COVID-19 vaccine development. They discuss J&J’s unique a…
  continue reading
 
Allison Pickens, former COO at Gainsight and co-author of “The Customer Success Economy: Why Every Aspect of Your Business Model Needs A Paradigm Shift” joins Venrock Partner Brian Ascher to discuss the new and increasingly important function of customer success for SaaS companies. They discuss how customer success differs from customer support, ho…
  continue reading
 
Venrock Partner Bob Kocher speaks with Ezekiel Emanuel, Vice Provost for Global Initiatives at the University of Pennsylvania and chair of the Department of Medical Ethics and Health Policy, about Emanuel’s upbringing and family, how to deliver better patient care and implications of data/AI for medical ethics. They speak about their time working t…
  continue reading
 
10x Genomics CEO and co-founder Serge Saxonov joins Venrock’s Bryan Roberts to discuss the founding of the company and its recent IPO. Saxonov shares his story of emigrating from Tajikistan to New York City as a teenager, learning English and becoming an entrepreneur. He talks candidly about how he’s grown as a leader over his six years as CEO of t…
  continue reading
 
Paul Koenig founded SRS Acquiom to make M&A deals more manageable for entrepreneurs. Venrock partner Brian Ascher speaks with Koenig about what he’s learned from seeing thousands of deals, including best practices for shareholder reps, common misconceptions about due diligence, and trends in all-cash vs. stock offers. They also discuss how entrepre…
  continue reading
 
Adam Boehler, CEO of the U.S. International Development Finance Corporation (DFC) and former Deputy Administrator for Innovation & Quality at the Center for Medicare and Medicaid Services, sits down with Venrock’s Bob Kocher to talk about the business of healthcare. He shares his journey from venture to founder to government, and he offers lessons …
  continue reading
 
Venrock’s David Pakman speaks with Misty Robotics Founder and Head of Product Ian Bernstein and CEO Tim Enwall about the launch of Misty II and the company’s evolution into a platform for developers. They discuss what sparked their initial interest in robotics and the various ways a robot can help people at home, from eldercare and cleaning to any …
  continue reading
 
Loading …

Quick Reference Guide